Published in Lancet on February 09, 2002
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
Neuroimaging of herpesvirus infections in children. Pediatr Radiol (2007) 2.13
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J Clin Microbiol (2004) 1.90
Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest (2011) 1.88
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Diagnosis and treatment of viral encephalitis. Postgrad Med J (2002) 1.55
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry (2004) 1.41
Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol (2012) 1.40
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
Efficient axonal localization of alphaherpesvirus structural proteins in cultured sympathetic neurons requires viral glycoprotein E. J Virol (2005) 1.36
Viral encephalitis. J Neurol (2005) 1.23
Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One (2008) 1.17
Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem (2010) 1.17
IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog (2014) 1.15
Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism. J Virol (2007) 1.15
Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis (2009) 1.14
Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation (2012) 1.08
Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol (2011) 1.07
Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J Virol (2008) 1.04
Infection-associated encephalopathies: their investigation, diagnosis, and treatment. J Neurol (2006) 1.03
Virus infection, antiviral immunity, and autoimmunity. Immunol Rev (2013) 1.00
Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis. PLoS Pathog (2015) 0.99
Estimation of dispersal distances of Culex erraticus in a focus of eastern equine encephalitis virus in the southeastern United States. J Med Entomol (2010) 0.98
Ebola: translational science considerations. J Transl Med (2015) 0.96
New estimates of incidence of encephalitis in England. Emerg Infect Dis (2013) 0.96
Normocellular CSF in herpes simplex encephalitis. BMC Res Notes (2016) 0.96
Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation. Clin Microbiol Rev (2009) 0.95
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol (2015) 0.93
Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia. J Neurol Neurosurg Psychiatry (2007) 0.92
Toscana meningoencephalitis: a comparison to other viral central nervous system infections. J Clin Virol (2012) 0.91
A case of maternal herpes simplex virus encephalitis during late pregnancy. Nat Clin Pract Neurol (2009) 0.91
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia (2014) 0.91
Unusual presentation of neurobrucellosis: a solitary intracranial mass lesion mimicking a cerebral tumor : a case of encephalitis caused by Brucella melitensis. J Infect Chemother (2012) 0.90
The neural F-box protein NFB42 mediates the nuclear export of the herpes simplex virus type 1 replication initiator protein (UL9 protein) after viral infection. Proc Natl Acad Sci U S A (2004) 0.90
Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. Emerg Infect Dis (2013) 0.89
Trends in encephalitis-associated deaths in the United States. Epidemiol Infect (2006) 0.87
Brainstem encephalitis: an unusual presentation of herpes simplex virus infection. J Neurol (2010) 0.87
Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain. J Virol (2006) 0.87
Five questions about viral trafficking in neurons. PLoS Pathog (2012) 0.85
Encephalitis and dengue. Lancet (2002) 0.85
Cofilin 1-mediated biphasic F-actin dynamics of neuronal cells affect herpes simplex virus 1 infection and replication. J Virol (2012) 0.84
Prevalence of herpes simplex virus (types 1 and 2), varicella-zoster virus, cytomegalovirus, and human herpesvirus 6 and 7 DNA in cerebrospinal fluid of Middle Eastern patients with encephalitis. J Clin Microbiol (2005) 0.83
Duck Tembusu virus exhibits neurovirulence in BALB/c mice. Virol J (2013) 0.82
Rabies in Iraq: trends in human cases 2001-2010 and characterisation of animal rabies strains from Baghdad. PLoS Negl Trop Dis (2013) 0.82
Autoimmunity-related demyelination in infection by Japanese encephalitis virus. J Biomed Sci (2011) 0.82
Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord (2012) 0.81
Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis. Cerebrospinal Fluid Res (2006) 0.81
Astragalus Polysaccharide Protects Astrocytes from Being Infected by HSV-1 through TLR3/NF-κB Signaling Pathway. Evid Based Complement Alternat Med (2014) 0.81
Human TBK1: A Gatekeeper of Neuroinflammation. Trends Mol Med (2016) 0.80
Development of a vaccine to prevent Japanese encephalitis: a brief review. Int J Gen Med (2009) 0.80
Gliomatosis cerebri mimicking acute viral encephalitis and with malignant transformation of partial lesions: A case report. Exp Ther Med (2014) 0.80
Should there be a standardised approach to the diagnostic workup of suspected adult encephalitis? A case series from Australia. BMC Infect Dis (2010) 0.80
Herpes simplex virus encephalitis in pregnancy - a case report and review of reported patients in the literature. BMC Res Notes (2015) 0.80
Western equine encephalitis virus: evolutionary analysis of a declining alphavirus based on complete genome sequences. J Virol (2014) 0.79
Defensive Perimeter in the Central Nervous System: Predominance of Astrocytes and Astrogliosis during Recovery from Varicella-Zoster Virus Encephalitis. J Virol (2015) 0.79
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system. Bioinformation (2015) 0.79
Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003-2005. Emerg Infect Dis (2015) 0.77
Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients. PLoS One (2016) 0.77
Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency. Virology (2016) 0.76
Interferon gamma protects neonatal neural stem/progenitor cells during measles virus infection of the brain. J Neuroinflammation (2016) 0.76
Seasonality of Viral Encephalitis and Associated Environmental Risk Factors in Son La and Thai Binh Provinces in Vietnam from 2004 to 2013. Am J Trop Med Hyg (2016) 0.75
Corticosteroid sensitivity in gliomatosis cerebri delays diagnosis. Pract Neurol (2015) 0.75
Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways. Antiviral Res (2016) 0.75
Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department. Emerg Med Clin North Am (2016) 0.75
Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls. Neurotherapeutics (2016) 0.75
MRI diagnosis of herpes simplex encephalitis in an elderly man with nonspecific symptoms. Radiol Case Rep (2016) 0.75
Neurological syndromes and the traveller: an approach to differential diagnosis. J Neurol Neurosurg Psychiatry (2004) 0.75
Tick fauna of Malaysian red jungle fowl (Gallus gallus) in Bangi, Malaysia. Vet World (2015) 0.75
Viral encephalitis. Lancet (2002) 0.75
Optimization of a combined human parechovirus-enterovirus real-time reverse transcription-PCR assay and evaluation of a new parechovirus 3-specific assay for cerebrospinal fluid specimen testing. J Clin Microbiol (2012) 0.75
Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. J Clin Invest (2017) 0.75
Acute encephalopathy associated with Campylobacter jejuni enteritis. Neurol Sci (2011) 0.75
Review of Viral Encephalitis Cases Seen at a Tertiary Care Center in Turkey: Focus on Herpes Simplex Type 1. Noro Psikiyatr Ars (2016) 0.75
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain (2008) 1.38
The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis (2008) 1.32
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther (2003) 1.18
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis (2013) 1.09
Herpes zoster in the age of focused immunosuppressive therapy. JAMA (2009) 1.07
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis (2009) 1.02
Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage (2002) 1.02
A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level. Clin Infect Dis (2003) 0.90
West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis (2014) 0.86
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. J Infect Dis (2013) 0.83
Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial. J Clin Virol (2008) 0.82
Reversible posterior leukoencephalopathy syndrome. Intern Emerg Med (2013) 0.78
The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis (2007) 0.75
Kaposi's varicelliform eruption. Intern Emerg Med (2013) 0.75